Pavani Chalasani ABRCC-2

    Clinical Researchers Showcase Series - January 2018

    Translational Medicine Research:

 View from the Trenches Newsletter


Brought to you by:

Criterium Logo Alt Tag Line w Globe Banner 2

Translational science is motivated by the need to provide effective treatments to the right patients at the right doses for a specific disease indication). The term is used mostly in the health sciences and refers to real-time translation of bench science, conducted only
in a lab, to bedside clinical practice or dissemination to population-based community interventions. (Source: NIH)

from the
Academic Breast Cancer Consortium

ABRCC Researcher Spotlight:

MEET Dr. Pavani Chalasani, M.D. MPH

University of Arizona Cancer Center, Tucson, AZ

ABRCC Investigator

Dr. Pavani Chalasani, MD, MPH, is the Assistant Professor of Medicine Divisions of Hematology-Oncology at the University of Arizona Cancer Center.


She attended medical school at Gandhi Medical College, Hyderabad, India and received her Master's Degree in Public Health from University of Massachusetts, Amherst. She completed her internal medical residency followed by fellowship in Hematology-Oncology at University of Arizona where she served as chief fellow during her final year of fellowship. Subsequently, she joined the breast medical oncology team at the University of Arizona Cancer Center.


She is one of seven junior faculty members to receive the inaugural Arizona Health Sciences Center Career Development Award which was designed to provide research training and funding opportunities for up to two years to foster an academic career in clinical and translational research.

She is the institutional Principal Investigator (PI) on multiple industry sponsored, and co-operative group protocols, and PI for several investigator-initiated clinical trials. She is a member of UACC’s  Scientific Review Committee which is responsible for critiquing and approving clinical trials. She has active collaborations with members in cancer biology, cancer prevention, and cancer imaging groups and have several ongoing investigator-initiated trials designed to better understand breast cancer biology and to develop predictive biomarkers.


About University of Arizona Cancer Center
designated by the National Cancer Institute as a Comprehensive Cancer Center, the NCI’s highest designation. That designation is reserved for centers focusing on patient care as well as basic and clinical research, prevention, education, outreach and training. The Cancer Center has an NCI Specialized Program of Research Excellence (SPORE) grant for gastrointestinal cancers and it also has a SPORE for lymphatic cancers. The Cancer Center is a leader in research on women’s cancers (breast, ovarian), men’s cancers (prostate), gastrointestinal cancers (colon, pancreas and liver), lymphoma and skin cancers and is home to one of the largest Cancer Prevention and Control Programs among the nation’s comprehensive cancer centers, with leading prevention research in breast, colon, lung, prostate and skin cancers. Learn more at: UACC.


for Translational Research

The important conceptual difference between the two predominant research group approaches used today (a Clinical Trials Group vs. Consortia) is seen in this consortia model.  With its highly experienced clinical scientists, ABRCC becomes involved on an intellectual advisory level with every step of clinical investigation in a breast cancer study. Classical clinical trials groups "just run the study" with the main substantive role being patient accrual.


To read more on ABRCC and the details of why the consortia model creates fast results, please visit our website.

The Oncology Consortia of Criterium

The Oncology Consortia of Criterium Global CRO are a collaboration of outstanding Cancer Research Consortia that deliver innovative research and unparalleled expertise:

  • AGICC:  Academic GI Cancer Consortium
  • AMyC:  Academic Myeloma Consortium
  • ATOMIC:  Academic Thoracic Oncology Medical Investigators Consortium
  • ABRCC:  Academic Breast Cancer Consortium

ABRCC Cube FULL Logo 2

Read more about Criterium Inc Global CRO

and The Oncology Consortia of Criterium on our website